William Blair Issues Positive Outlook for ZVRA Earnings
Zevra Therapeutics, Inc. (NASDAQ:ZVRA – Free Report) – Research analysts at William Blair raised their Q2 2025 earnings estimates for shares of Zevra Therapeutics in a note issued to investors on Wednesday, May 14th. William Blair analyst S. Corwin now expects that the company will post earnings per share of ($0.09) for the quarter, up […]
Zevra Therapeutics, Inc. (NASDAQ:ZVRA – Free Report) – Research analysts at William Blair raised their Q2 2025 earnings estimates for shares of Zevra Therapeutics in a note issued to investors on Wednesday, May 14th. William Blair analyst S. Corwin now expects that the company will post earnings per share of ($0.09) for the quarter, up […]
